Foscavir (Foscarnet sodium) is an effective antiviral medication that doesn’t end with dosing but rather careful monitoring is needed. Let’s understand in which conditions Foscavir is used and what are the protocols one should follow while taking it.
For patients researching foscarnet injection in India, understanding its approved uses, dosing, monitoring and precautions is important before treatment is considered.
Fosacvir is used to treat?
- Cytomegalovirus (CMV) Retinitis in patients with acquired immunodeficiency syndrome (AIDS).
- Mucocutaneous Acyclovir Resistant Herpes Simplex Virus (HSV) infections.
For patients specifically looking for foscavir 24 mg/mL in India, the prescribed formulation and treatment requirements should be confirmed with a qualified healthcare professional.
How does it work?
Foscavir directly inhibits viral DNA polymerase (enzyme) that interferes with viral DNA synthesis. Eventually, the virus cannot reproduce normally and viral replication slows down, thereby controlling the disease progression.
Foscavir requires careful consideration of its clinical use, particularly because treatment can involve significant renal and electrolyte-related concerns. For a broader overview of its indications, safety and access considerations in India, you can also read our detailed guide on Foscavir.
How is it given?
Induction (Initial) Treatment
The recommended initial dose of Foscavir for patients with normal renal function is:
- For CMV retinitis patients, either 90 mg/kg (1-1/2 to 2 hour infusion) every twelve hours or 60 mg/kg (minimum one hour infusion) every eight hours over 2-3 weeks depending on clinical response.
- For acyclovir-resistant HSV patients, 40 mg/kg (minimum one hour infusion) either every 8 or 12 hours for 2-3 weeks or until healed.
When evaluating foscarnet 24 mg/ml cost in India, the overall treatment requirements and duration should be considered rather than focusing only on the medicine cost.
Proper hydration is recommended to establish a diuresis (increased production of urine), both prior to and during treatment to minimize renal toxicity, provided there are no clinical contraindications. This reduces the risk of nephrotoxicity.
Maintenance Treatment
Following induction treatment the recommended maintenance dose of Foscavir for CMV retinitis is 90 mg/kg/day to 120 mg/kg/day (individualized for renal function) given as an intravenous infusion over 2 hours.
Again, hydration to establish diuresis both prior to and during treatment is recommended to minimize renal toxicity, provided there are no clinical contraindications.
Patients checking foscavir availabilty in India should also consider the prescription, medical supervision and appropriate treatment requirements associated with this medicine.
Possible side-effects
- Renal impairment
- Mineral and electrolyte abnormalities
- Seizures
- Hypersensitivity
- QT prolongation (delayed electrical recovery of the heart) and torsade de pointes (irregular heart rhythm).
The foscavir price in India may vary depending on the prescribed formulation, sourcing requirements and other treatment-related factors.
Monitoring
Every Foscavir dosing is associated with monitoring of the following factors:
- Kidney function assessment
- Hydration levels analysis
- Serum electrolytes like serum calcium, magnesium, potassium and phosphorus.
- Symptoms of serious hypersensitivity reactions like anaphylactic shock, urticaria, angioedema are checked.
Since Foscavir therapy involves individualized dosing and regular monitoring, understanding its potential adverse effects is also important. Read our detailed guide covering Foscavir uses, dosage, side effects and monitoring for additional information.
Precautions
- Male and female genital irritation/ulceration may occur in patients taking Foscavir therapy. Adequate hydration along with personal hygiene may minimize the occurrence of such events.
- An infusion pump must be used for administration to prevent rapid intravenous infusion. Slowing the infusion rate may decrease or prevent symptoms of electrolyte abnormalities, seizures and tetany and cardiac disturbances.
- In patients with cardiomyopathy, Foscavir is avoided when intravenous infusion of a large amount of sodium or water may not be tolerated.
- Foscavir is avoided in patients on a controlled sodium diet.
- CMV retinitis patients are advised to go for regular ophthalmologic examinations because this condition may prolong during and following the therapy.
- Repeated therapies with Foscavir in patients with Mucocutaneous Acyclovir-Resistant HSV Infections may cause resistance development, so sensitivity testing of the viral isolate also is advised.
- Patients are advised to avoid driving or operating machinery who experience seizures, dizziness and somnolence that may worsen.
- Patients should be advised of the importance of reporting to their physicians symptoms of perioral tingling, numbness in the extremities or paresthesias during or after infusion as possible symptoms of electrolyte abnormalities.
- Patients should also be advised to promptly report any cardiac symptoms. The infusion should be stopped, appropriate laboratory samples for assessment of electrolyte concentrations obtained, and a physician consulted before resuming treatment. The rate of infusion must be no more than 1 mg/kg/minute.
- The potential for renal impairment may be minimized by combining Foscavir administration with hydration adequate to establish and maintain a diuresis during dosing.
Patients who need to import foscavir in India should follow the applicable prescription and regulatory requirements and obtain appropriate medical guidance before treatment.
Foscavir treats serious viral infections but its safety lies in evaluating its effectiveness and prolonged monitoring throughout and following the treatment. Patients can also review our detailed Foscavir indications and safety guide for additional information.
